These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31695027)

  • 1. Molecular basis for chirality-regulated Aβ self-assembly and receptor recognition revealed by ion mobility-mass spectrometry.
    Li G; DeLaney K; Li L
    Nat Commun; 2019 Nov; 10(1):5038. PubMed ID: 31695027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?
    Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT
    J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer's disease on Aβ1-40 peptide early assembly.
    Lazzaro S; Ogrinc N; Lamont L; Vecchio G; Pappalardo G; Heeren RMA
    Anal Bioanal Chem; 2019 Sep; 411(24):6353-6363. PubMed ID: 31407050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.
    Zheng X; Liu D; Roychaudhuri R; Teplow DB; Bowers MT
    ACS Chem Neurosci; 2015 Oct; 6(10):1732-40. PubMed ID: 26244608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity cross-linking of Alzheimer's disease amyloid fibrils reveals interstrand contact regions between assembled beta-amyloid peptide subunits.
    Egnaczyk GF; Greis KD; Stimson ER; Maggio JE
    Biochemistry; 2001 Oct; 40(39):11706-14. PubMed ID: 11570871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
    Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
    Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
    Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
    J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminal Hypothesis for Alzheimer's Disease.
    Murray B; Sharma B; Belfort G
    ACS Chem Neurosci; 2017 Mar; 8(3):432-434. PubMed ID: 28186729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of beta-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy.
    Ionuţ Iuraşcu M; Cozma C; Tomczyk N; Rontree J; Desor M; Drescher M; Przybylski M
    Anal Bioanal Chem; 2009 Dec; 395(8):2509-19. PubMed ID: 19838688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta(1-40) peptide radiopharmaceuticals for brain amyloid imaging: (111)In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections.
    Kurihara A; Pardridge WM
    Bioconjug Chem; 2000; 11(3):380-6. PubMed ID: 10821654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the hetero-assembly of β-amyloid peptide with islet amyloid polypeptide.
    Yan LM; Velkova A; Kapurniotu A
    Curr Pharm Des; 2014; 20(8):1182-91. PubMed ID: 23713771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and structural characterisation of carboxy-terminal polypeptides and antibody epitopes of Alzheimer's amyloid precursor protein using high-resolution mass spectrometry.
    Tian X; Cecal R; McLaurin J; Manea M; Stefanescu R; Grau S; Harnasch M; Amir S; Ehrmann M; St George-Hyslop P; Kohlmann M; Przybylski M
    Eur J Mass Spectrom (Chichester); 2005; 11(5):547-56. PubMed ID: 16322661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
    Asadbegi M; Shamloo A
    ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.
    Cabrera E; Mathews P; Mezhericher E; Beach TG; Deng J; Neubert TA; Rostagno A; Ghiso J
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):208-225. PubMed ID: 28711595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of terminal groups and halogenation of KLVFF peptide on its activity as an inhibitor of β-amyloid aggregation.
    Khalili Samani E; Mofid MR; Malakoutikhah M
    J Pept Sci; 2020 Feb; 26(2):e3227. PubMed ID: 31845472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease.
    Portelius E; Olsson M; Brinkmalm G; Rüetschi U; Mattsson N; Andreasson U; Gobom J; Brinkmalm A; Hölttä M; Blennow K; Zetterberg H
    J Alzheimers Dis; 2013; 33(1):85-93. PubMed ID: 22886024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.